Company
Company
No. 1445 of 75986top 2%up 1136 places this week
10 direct links
In a group of 304 closely linked entities, around
New links this week
Weighted by public relations with evidence, recomputed daily.
Arrows show the direction of the relationship. Filter to focus on a business area.
a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934View source
a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5View source
for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.View source
a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5View source
providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas.View source
Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sitesView source
increased demand across Performance Solutions' high-value AI infrastructure including data center and semiconductor end marketsView source
increased demand across Performance Solutions' high-value AI infrastructure including data center and semiconductor end marketsView source
Chemours is an American chemical companyView source
Chemours is an American chemical companyView source
Showing 1 to 8 of 13
Read the assertion alongside its sources. Expand a row to inspect the evidence.
with Adjusted EBITDA between $775 million and $800 million.
PR Newswire news releases · 2026-11-03 05:30
with Adjusted EBITDA between $775 million and $800 million.View source
with overall Free Cash Flow Conversion above 15%
PR Newswire news releases · 2026-11-03 05:30
with overall Free Cash Flow Conversion above 15%View source
which includes receipt of $150 million in restricted cash related to the PFAS insurance proceeds MOU
PR Newswire news releases · 2026-11-03 05:30
which includes receipt of $150 million in restricted cash related to the PFAS insurance proceeds MOUView source
The Company expects 2026 Net Sales to grow approximately 2% over 2025
PR Newswire news releases · 2026-11-03 05:30
The Company expects 2026 Net Sales to grow approximately 2% over 2025View source
Capital expenditures are anticipated to be between $220 million and $230 million
PR Newswire news releases · 2026-11-03 05:30
Capital expenditures are anticipated to be between $220 million and $230 millionView source
Debt, net of $698 million in unrestricted4 cash and cash equivalents, was $3.2 billion
PR Newswire news releases · 2026-11-03 05:30
Debt, net of $698 million in unrestricted4 cash and cash equivalents, was $3.2 billionView source
Showing 1 to 6 of 40
Valuation data is available on Pro and Research.
Included in ProKnow a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.
Not available: Company signals · Financials · Filings · Sites · Guidance